TIS21/BTG2 inhibits invadopodia formation by downregulating reactive oxygen species level in MDA-MB-231 cells

Journal of Cancer Research and Clinical Oncology

Volumn 139, Issue 10, 2013, Pages 1657-1665

  Choi, Jung A ^a   Lim, In Kyoung ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Breast cancer cells; F actin remodeling; Invadopodia; Reactive oxygen species (ROS); TIS21 BTG2 Pc3

Indexed keywords

ACTIN; ADENOVIRUS VECTOR; BETA GALACTOSIDASE; F ACTIN; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; HUMAN; HUMAN CELL; INVADOPODIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; TIS21 GENE; TUMOR INVASION; TUMOR SUPPRESSOR GENE; VIRAL GENE DELIVERY SYSTEM;

ACTIN CYTOSKELETON; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURFACE EXTENSIONS; DOWN-REGULATION; FEMALE; FOCAL ADHESIONS; HUMANS; IMMEDIATE-EARLY PROTEINS; MICE; MICE, KNOCKOUT; NEOPLASM INVASIVENESS; REACTIVE OXYGEN SPECIES; TUMOR SUPPRESSOR PROTEINS;

EID: 84884671536     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-013-1484-3     Document Type: Article

References (33)

1. Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller FC et al (2006) Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res 66:3034-3043
2. Ben Mahdi MH, Andrieu V, Pasquier C (2000) Focal adhesion kinase regulation by oxidative stress in different cell types. IUBMB Life 50:291-299
3. Bradbury A, Possenti R, Shooter EM et al (1991) Molecular cloning of PC3, a putatively secreted protein whose mRNA is induced by nerve growth factor and depolarization. Proc Natl Acad Sci USA 88:3353-3357
4. Buccione R, Orth JD, McNiven MA (2004) Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nat Rev Mol Cell Biol 5:647-657
5. Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563-572
6. Chiarugi P, Pani G, Giannoni E et al (2003) Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J Cell Biol 161:933-944
7. Clark ES, Whigham AS, Yarbrough WG et al (2007) Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res 67:4227-4235
8. Coopman PJ, Do MT, Thompson EW et al (1998) Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. Clin Cancer Res 4:507-515
9. Diaz B, Shani G, Pass I et al (2009) Tks5-dependent, nox-mediated generation of reactive oxygen species is necessary for invadopodia formation. Sci Signal 2:ra53
10. Eckert MA, Lwin TM, Chang AT et al (2011) Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell 19:372-386
11. Farioli-Vecchioli S, Cinà I, Ceccarelli M et al (2012) TIS21 knock-out enhances the frequency of medulloblastoma in Patched1 heterozygous mice by inhibiting the Cxcl3-dependent migration of cerebellar neurons. J Neurosci 32:15547-15564
12. Ficazzola MA, Fraiman M, Gitlin J et al (2001) Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis. Carcinogenesis 22:1271-1279
13. Fletcher BS, Lim RW, Varnum BC et al (1991) Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters. J Biol Chem 266:14511-14518
14. Kawakubo H, Brachtel E, Hayashida T et al (2006) Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein. Cancer Res 66:7075-7082
15. Lim IK (2006) TIS21(/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule. J Cancer Res Clin Oncol 132:417-426
16. Lim IK, Lee MS, Lee SH et al (1995) Differential expression of TIS21 and TIS1 genes in the various organs of Balb/c mice, thymic carcinoma tissues and human cancer cell lines. J Cancer Res Clin Oncol 121:279-284
17. Linder S, Aepfelbacher M (2003) Podosomes: adhesion hot-spots of invasive cells. Trends Cell Biol 13:376-385
18. Mader CC, Oser M, Magalhaes MA et al (2011) An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion. Cancer Res 71:1730-1741
19. Matsuda S, Rouault J, Magaud J et al (2001) In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Lett 497:67-72
20. Melamed J, Kernizan S, Walden PD (2002) Expression of B-cell translocation gene 2 protein in normal human tissues. Tissue Cell 34:28-32
21. Park S, Lee YJ, Lee HJ et al (2004) B-cell translocation gene 2 (Btg2) regulates vertebral patterning by modulating bone morphogenetic protein/smad signaling. Mol Cell Biol 24:10256-10262
22. Park TJ, Kim JY, Oh SP et al (2008) TIS21 negatively regulates hepatocarcinogenesis by disruption of cyclin B1-Forkhead box M1 regulation loop. Hepatology 47:1533-1543
23. Rouault JP, Falette N, Guéhenneux F et al (1996) Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet 14:482-486
24. Schmidt M, Böhm D, von Törne C et al (2008) The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res 68:5405-5413
25. Struckmann K, Schraml P, Simon R et al (2004) Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma. Cancer Res 64:1632-1638
26. Stylli SS, Kaye AH, Lock P (2008) Invadopodia: at the cutting edge of tumour invasion. J Clin Neurosci 15:725-737
27. Takahashi F, Chiba N, Tajima K et al (2011) Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib. Oncogene 30:3084-3095
28. Tobar N, Cáceres M, Santibáñez JF et al (2008) RAC1 activity and intracellular ROS modulate the migratory potential of MCF-7 cells through a NADPH oxidase and NFkappaB-dependent mechanism. Cancer Lett 267:125-132
29. Turner DP, Moussa O, Sauane M et al (2007) Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer. Cancer Res 67:1618-1625
30. van't Veer LJ, Dai H, van de Vijver MJ et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536
31. Yamaguchi H, Lorenz M, Kempiak S et al (2005a) Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J Cell Biol 168:441-452
32. Yamaguchi H, Wyckoff J, Condeelis J (2005b) Cell migration in tumors. Curr Opin Cell Biol 17:559-564
33. Yamaguchi H, Takeo Y, Yoshida S et al (2009) Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells. Cancer Res 69:8594-8602